Showing 24 out of 59 results
Digital forensics in investigations and the growing data burden
Businesses will need smarter data collection and management strategies to satisfy regulators The approach to digital forensics in investigations is …
Using big data to fight financial crime
In a regulatory environment which demands ever higher standards for anti-money laundering (AML) compliance, many financial institutions have responded by …
Regulators lead businesses in monitoring of misconduct
As regulators and law enforcement increasingly rely on advanced data analytics for monitoring and surveillance, the risk is growing that they will detect …
Big data and Modern Slavery – Progress not panacea
Data analysis can only get you so far in modern slavery compliance… and regulators are watchingWhile the benefits of data and technology can be leveraged …
Future Cities Series: How planning and zoning rules can drive post-Covid development
The evolution of cities has long been defined by threats and crisis. Covid-19 will be no exception.The Covid-19 pandemic has spread rapidly in densely …
Governance: Corporate Insolvency and Governance Bill: impact on supply chains and their customers (UK)
Update; The Corporate Insolvency and Governance Act 2020 commenced into effect on 26 June 2020. While the final provisions of the Act largely reflected …
Herbert Smith Freehills advises Achilles Vaccines in record seed financing for biotech sector
Herbert Smith Freehills has advised Achilles Vaccines, a biotech company focusing on the research and development of vaccines against malaria and other …
Patent and Pharma Update, May 2020
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector In this update we welcome our new IP partner …
Exploring Opportunities: The impact of Covid-19 on competition law in the pharmaceutical sector (Europe)
The global Covid-19 pandemic has, to an extent, re-directed some of the actions and focus of competition authorities, which are placing increasing …
Patent and Pharma Update, February 2020
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector In this issue we report on the Supreme Court …
ECJ rules for the first time on “pay-for-delay” agreements
On 30 January 2020 the European Court of Justice (“ECJ”) clarified for the first time the criteria governing whether so-called “pay-for-delay” agreements …
Medicines for the Many – a reaction from Herbert Smith Freehills
Responding to the publication of the Labour Party's manifesto and the 'Medicines for the Many' report – the Party's proposed policies on access to …
Showing 24 out of 59 results
View more